Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema
- DOI
- 10.1007/s12325-026-03625-0
- Published
- 2026-05-20
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03625-0,
title = {Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema},
author = {Marc A. Riedl and Nihal Narsipur and Douglas Jones and Raffi Tachdjian and Anurag Relan and Hannah Kilvert and Emily Aiello and Ketsia Habimana and Neil Roskell and Adam Gough and Joseph R. Harper and H. Henry Li and Amanda Harrington},
year = {2026},
journal = {Advances in Therapy},
doi = {10.1007/s12325-026-03625-0},
url = {https://doi.org/10.1007/s12325-026-03625-0}
}RIS
TY - JOUR TI - Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema AU - Marc A. Riedl AU - Nihal Narsipur AU - Douglas Jones AU - Raffi Tachdjian AU - Anurag Relan AU - Hannah Kilvert AU - Emily Aiello AU - Ketsia Habimana AU - Neil Roskell AU - Adam Gough AU - Joseph R. Harper AU - H. Henry Li AU - Amanda Harrington PY - 2026 JO - Advances in Therapy DO - 10.1007/s12325-026-03625-0 UR - https://doi.org/10.1007/s12325-026-03625-0 ER -
APA
Riedl, M. A., Narsipur, N., Jones, D., Tachdjian, R., Relan, A., Kilvert, H., Aiello, E., Habimana, K., Roskell, N., Gough, A., Harper, J. R., Li, H. H., & Harrington, A. (2026). Post Hoc Analysis of Recombinant C1 Inhibitor Clinical Data Using Contemporary Endpoints for Hereditary Angioedema. Advances in Therapy. https://doi.org/10.1007/s12325-026-03625-0
Source records
- crossref · retrieved 2026-09-25T19:29:01.792Z